Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip
DAIC
APRIL 2, 2024
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 On average, noted Abbott, people who receive TriClip only need one day in the hospital before they recover and can return home. Abbott has announced U.S million people in the U.S.
Let's personalize your content